期刊文献+

重型再生障碍性贫血患者外周血调节性T细胞的数量异常及其临床意义 被引量:9

Abnormal Quantity of Regulatory T Cells in Peripheral Blood of Patients with Severe Aplastic Anemia and Its Clinical Significance
下载PDF
导出
摘要 本研究旨在探讨调节性T细胞(Treg)在重型再生障碍性贫血(SAA)患者免疫失衡中的意义。采用流式细胞术检测44例SAA患者(初治25例、缓解19例)及23名健康对照者外周血CD4+CD25+CD127dimTreg数量,分析其与T细胞亚群(CD4+/CD8+比值)、树突细胞(DC)亚群(mDC/pDC比值)和白细胞(WBC)、网织红细胞百分比(Ret%)表达的相关性。结果表明,初治组CD4+CD25+CD127dim占外周血淋巴细胞(PBL)比例为(0.83±0.44)%,明显低于SAA患者恢复组(2.91±1.24)%(P<0.05)及对照组(2.18±0.55)%(P<0.05),而恢复组与对照组比较差异无统计学意义(P>0.05)。初治组CD4+/CD8+比值为(0.5±0.3)明显低于恢复组(1.2±0.4)(P<0.05)及对照组(1.11±0.24)(P<0.05)。初治组mDC/pDC比值为(3.08±0.72)明显高于恢复组(1.61±0.49)(P<0.05)及对照组(1.39±0.36)(P<0.05)。SAA患者CD4+CD25+CD127dim/PBL与CD4+/CD8+比值呈正相关(r=0.695,P<0.01),而与mDC/pDC比值呈负相关(r=-0.796,P<0.01);SAA患者CD4+CD25+CD127dim/PBL与外周血WBC计数及RET%呈正相关(r=0.761,P<0.01;r=0.749,P<0.01)。结论:SAA患者外周血CD4+CD25+CD127dimTreg占淋巴细胞百分比降低,是引起免疫耐受被破坏、T细胞功能亢进,进而导致造血功能衰竭的机制之一。 This study was purposed to investigate the role of regulatory T cells (Treg) in the immune unbalance for patients with acquired severe aplastic anemia (SAA). The flow cytometry was used to detect the quantity of CD4 + CD25 + CD127+m Tregs, T cell subset( CD4 +/CD8 + ratio), dendritic cell(DC) subset( mDC/pDC ratio) in 44 SAA patients(25 untreated patients and 19 recovery patients) and 23 normal controls. The correlation between Tregs and T cell subset, DC subset and hemogram were analyzed. The results showed that the percentage of CD4 + CD25 + CD127+m Tregs in peripheral blood lymphocyte(PBL) of untreated patients was (0.83 ± 0.44)% , which was obviously lower than that in recovery patients ( 2.91 ± 1.24) % and normal controls ( 2.18 ±- 0.55 ) % ( P 〈 0.05 ), but the difference was not statistically significant between latter two groups. The ratio of CD4 +/CD8+was (0.5 ± 0.3 ) in untreated patients, which was obviously lower than that in recovery patients ( 1.2 + 0.4) and normal controls ( 1.11 + 0.24) ( P 〈 0. 05). The ratio of mDC/pDC was (3.08 -± 0.72) in untreated patients, which was significantly higher than that in recovery patients( 1.61 ± 0.49 ) and normal controls ( 1.39 ± 0. 36 ) ( P 〈 0.05 ). The percentage of CD4 + CD25 + CD127+jm Tregs in PBL positively correlated with CIM ±/CD8 ± ratio ( r = 0. 695, P 〈 0.01 ), and that negatively correlated with mDC/pDC ratio ( r = - 0. 796, P 〈 0.01 ). There were significant positive correlations between CD4 + CD25 ± CD127dim Tregs/PBL and WBC, Ret% ( r = 0. 761, 0. 749 respectively, P 〈 0.01 ). It is concluded that the decrease of CD4 + CD25 + CD127aim Tregs quantity in SAA may be one of mechanisms underlying bone marrow failure resulting from the deterioration of immune tolerance and hyperfunction of T-cells.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第4期1043-1046,共4页 Journal of Experimental Hematology
基金 国家自然科学基金(81170472 81370607) 天津市自然科学基金重点项目(12JCZDJC21500) 天津市抗癌重大专项攻关计划(12ZCDZSY17900 12ZCDZSY18000) 天津市卫生行业重点攻关项目(11KG135) 卫生行业科研专项项目(201202017)
关键词 重型再生障碍性贫血 调节性T细胞 骨髓衰竭 severe aplastic anemia regulatory T cell bone marrow failure
  • 相关文献

参考文献13

  • 1Young NS,Scheinberg P,Calado RT.Aplastic anemia.Curr Opin Hematol,2008;15(3):162-168.
  • 2杨友卫,郑智茵,姚红章.Th17/Treg细胞失衡与再生障碍性贫血研究进展[J].中国实验血液学杂志,2012,20(1):214-218. 被引量:21
  • 3涂梅峰,邵宗鸿,刘鸿,何广胜,付蓉,施均,白洁,曹燕然,王化泉,邢莉民,崔振珠,孙娟,贾海蓉,陈辉树,薛艳萍,杨崇礼.重型再生障碍性贫血患者Th3细胞、调节T细胞数量和转化生长因子β1的水平[J].中华血液学杂志,2006,27(11):753-756. 被引量:22
  • 4杨崇礼.再生障碍性贫血[A].见:张之南主编.血液病诊断和疗效标准:第2版[C].北京:科学出版社,1998.33~42.
  • 5Onishi Y,Fehervari Z,Yamaguchi T,et al.Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation.Proc Natl Acad Sci USA,2008;105(29):10113-10118.
  • 6Bergmann C,Wild CA,Narwan M,et al.Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.Eur J Immunol,2011;41(12):3564-3573.
  • 7Golding A,Hasni S,Illei G,et al.The percentage of FoxP3+Helios+Treg cells correlates positively with disease activity in systemic lupus erythematosus.Arthritis Rheum,2013;65(11):2898-2906.
  • 8Aboul-Fotoh Lel-M,Abdel Raheem MM,EI-Deen MA,et al.Role of CD4+CD25+T cells in children with idiopathic thrombocytopenic purpura.J Pediatr Hematol Oncol,2011;33(2):81-85.
  • 9Soler DC,Sugiyama H,Young AB,et al.Psoriasis patients exhibit impairment of the high potency CCR5(+)T regulatory cell subset.Clin Immunol,2013;149(1):111-118.
  • 10Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003;299(5609):1057-1061.

二级参考文献21

  • 1Koenders MI,Lubberts E,Oppers-Walgreen B,et al.Blocking ofinterleukin-17 during reactivation of experimental arthritis preventsjoint inflammation and bone erosion by decreasing RANKL andinterleukin-1.Am J Pathol,2005;167(1):141-149.
  • 2Hofstetter HH,Ibrahim SM,Koczan D,et al.Therapeutic efficacyof IL-17 neutralization in murine experimental autoimmuneencephalomyelitis.Cell Immunol,2005;237(2):123-130.
  • 3Solomou EE,Rezvani K,Mielke S,et al.Deficient CD4^+CD25^+Foxp3^+ T regulatory cells in acquired aplastic anemia.Blood,2007;110(5):1603-1606.
  • 4Shen H,Goodall JC,Hill Gaston JS.Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.Arthritis Rheum,2009;60(6):1647-1656.
  • 5Xu L,Xu W,Wen Z,et al.In situ prior proliferation of CD4+CCR6+regulatory T cells facilitated by TGF-βsecreting DCs iscrucial for their enrichment and suppression in tumor immunity.PLoS One,2011;6(5):e20282.
  • 6Elias KM,Laurence A,Davidson TS,et al.Retinoic acid inhibitsTh17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway.Blood,2008;111(3):1013-1020.
  • 7Xu L,Kitani A,Fuss I,et al.Cutting edge:regulatory T cellsinduce CD4+CD25-Foxp3-T cells or are self-induced to becomeTh17 cells in the absence of exogenous TGF-beta.J Immunol,2007;178(11):6725-6729.
  • 8Platanias LC.Abnormalities in Th17 T cells in aplastic anemia.Blood,2010;116(20):4039-4040.
  • 9Solomou EE,Keyvanfar K,Young NS.T-bet,a Th1 transcriptionfactor,is up-regulated in T cells from patients with aplastic anemia.Blood,2006;107(10):3983-3991.
  • 10Tang Y,Desierto MJ,Chen J,et al.The role of the Th1transcription factor T-bet in a mouse model of immune-mediatedbone-marrow failure.Blood,2010;115(3):541-548.

共引文献54

同被引文献108

  • 1施海涛,王金环,孙岸弢,雍延礼,孙伟正.补肾生血法对慢性再生障碍性贫血患者信号转导MAPK通路的影响[J].中医药学报,2011,39(4):49-52. 被引量:10
  • 2张涛,孙秉中,陈协群,朱华锋,乔庆大.Th1/Th2细胞对再生障碍性贫血CD34^+细胞体外扩增和集落形成的影响[J].细胞与分子免疫学杂志,2006,22(3):353-355. 被引量:5
  • 3Brummendorf TH;Macie JP;Mak J.Telomere length in leukocyte subpopulations of patients with aplastic anemia,2001(04).
  • 4Neal S Young,Phillip Scheinberg,Rodrigo T Calado.Aplastic anemia[J]. Current Opinion in Hematology . 2008 (3)
  • 5Robert A Brodsky,Richard J Jones.Aplastic anaemia[J]. The Lancet . 2005 (9471)
  • 6VikasGupta,Edward C.Gordon‐Smith,GordonCook,AnneParker,Jennifer K.M.Duguid,Keith M.O.Wilson,Qi‐LongYi,Judith C.W.Marsh.A third course of anti‐thymocyte globulin in aplastic anaemia is only beneficial in previous responders[J]. British Journal of Haematology . 2005 (1)
  • 7Ahmed Parvez,Chaudhry Qamar-un-Nisa,Raza Shahid,Mahmood Syed Kamran,Satti Tariq Mehmood,Anwar Masood,Altaf Chaudhry,Shahbaz Nighat,Satti Humayoon Shafique.Outcome of allogeneic haematopoietic stem cell transplantation in aplastic anaemia. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP . 2012
  • 8Sun Zi-Min,Liu Hui-Lan,Geng Liang-Quan,Wang Xin-Bing,Yao Wen,Liu Xin,Ding Kai-Yang,Han Yong-Sheng,Yang Hui-Zhi,Tang Bo-lin,Tong Juan,Zhu Wei-Bo,Wang Zu-Yi.HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia. Journal of Hematology & Oncology . 2010
  • 9Bacigalupo A.Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplantation . 2008
  • 10Frickhofen N,Heimpel H,Kaltwasser J P,et al.Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood . 2003

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部